Open original FDA record ↗Recall record
- FDA identifier
- Z-0758-04
- Company in FDA record
- Baxter Healthcare Renal Div
- FDA classification date
- Jul 20, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Microbubbles of air in the extracorporeal blood circuit during hemodialysis therapy on the Meridian.
Source facts
- Action
- Urgent Device Correction letters dated 3/11/04 were sent to all Meridian users, informing them of adverse events associated with air in the extracorporeal blood circuit during hemodialysis therapy on the Meridian. The letter outlined the clinical practices that must be followed for all hemodialysis therapies to reduce the potential for air to be introduced into the extracorporeal blood circuit during hemodialysis. Any questions or related events to report were directed to Baxter Instrument Services at 1-800-553-6898, select prompt 3, option 2 and choice 2. Baxter developed a permanent fix -- an enhanced air detector with improved sensitivity, making it capable of detecting air bubbles of a smaller size. Letters were sent to all Meridian customers on 7/11/05, informing them of the availability of the new detector and that a Baxter Field Service Engineer would contact them to schedule the upgrade.
- Initiated
- 2004-03-10
- Root cause
- Other
- Terminated
- 2006-10-26
- Distribution
- Nationwide, Mexico, China and Korea.
- Recall number
- Z-0758-04
- Recall status
- Terminated
- CDRH record ID
- 31970
- FDA classified
- 2004-07-20
- Recall event number
- 28475